Day: April 1, 2025

Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease

Collaboration leverages Logica, a platform offering from Valo Health and Charles River that directly translates biological insights into optimized small molecules...

Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC

News Summary Boosts out-of-the-box sensitivity by up to 80 times with MaxPeakTM Premier columns.1Delivers over threefold improvements in day-to-day reproducibility2...

ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience

Study Captures Drivers and Deterrents to Digital Health to Inform Biopharma Cx, Commercialization and Marketing Efforts SAN FRANCISCO, April 1,...

Policy Reporter by Mercalis and AccessSync Announce Strategic Partnership to Transform Market Access Capabilities

Collaboration integrates comprehensive payer policy intelligence with Access Realization™ solutions to overcome market access complexity for life sciences products MORRISVILLE,...

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

Publication of Independent Study Heightens Demand for UroShield ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company” or “NanoVibronix”), a medical...

error: Content is protected !!